RICHMAN ERIC I

CIK 00013138765 companiesANNAPOLIS, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001313876

Recent Transactions

50 trades

Award
Gain Therapeutics, Inc.$GANX
Stock Option (right to buy)
2025-06-24+15,000→ 15,000 total
Purchase
Gain Therapeutics, Inc.$GANX
Common Stock
2024-07-01$1.21/sh+12,000→ 289,629 total
Purchase
Gain Therapeutics, Inc.$GANX
Common Stock
2024-07-01$1.23/sh+5,000→ 277,629 total
Award
Gain Therapeutics, Inc.$GANX
Stock Option (right to buy)
2024-06-24+15,000→ 15,000 total
Exercise/Conversion
Gain Therapeutics, Inc.$GANX
Restricted Stock Units
2023-09-20−54,900→ 0 total
Exercise/Conversion
Gain Therapeutics, Inc.$GANX
Common Stock
2023-09-20+54,900→ 272,629 total
Award
Gain Therapeutics, Inc.$GANX
Employee Stock Option (right to buy)
2022-09-20+329,400→ 329,400 total
Award
Gain Therapeutics, Inc.$GANX
Restricted Stock Units
2022-09-20+54,900→ 54,900 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2022-09-09+37,600→ 37,600 total
Purchase
Gain Therapeutics, Inc.$GANX
Common stock
2022-05-25$2.58/sh+2,482→ 217,729 total
Purchase
Gain Therapeutics, Inc.$GANX
Common Stock
2022-05-20$2.83/sh+9,256→ 215,247 total
Purchase
Gain Therapeutics, Inc.$GANX
Common stock
2022-05-19$2.71/sh+4,000→ 205,991 total
Purchase
NeuBase Therapeutics, Inc.
Common stock
2022-03-04$1.62/sh+1,000→ 44,960 total
Purchase
NeuBase Therapeutics, Inc.
Common stock
2022-03-03$1.72/sh+1,300→ 43,960 total
Purchase
NeuBase Therapeutics, Inc.
Common stock
2022-03-01$1.58/sh+1,580→ 42,660 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2021-08-19+38,135→ 38,135 total
Purchase
Gain Therapeutics, Inc.$GANX
Common Stock
2021-08-16$7.87/sh+4,922→ 216,820 total
Exercise/Conversion
Gain Therapeutics, Inc.$GANX
Common Stock
2021-08-16$7.87/sh+4,922→ 216,820 total
Purchase
NeuBase Therapeutics, Inc.
Common stock
2021-04-26$5.00/sh+5,000→ 41,080 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2020-09-09+14,634→ 14,634 total
Purchase
NeuBase Therapeutics, Inc.
Common stock
2020-04-30$6.00/sh+8,333→ 36,080 total
Purchase
NeuBase Therapeutics, Inc.
Common stock
2020-04-30$6.00/sh+2,500→ 27,747 total
Award
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2020-02-28+7,500→ 44,030 total
Award
ADMA BIOLOGICS, INC.$ADMA
Employee Stock Option (right to buy)
2020-02-28+15,000→ 15,000 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2019-07-12+227,330→ 227,330 total
Award
NeuBase Therapeutics, Inc.
Common stock
2019-07-12+25,247→ 25,247 total
Award
ADMA BIOLOGICS, INC.$ADMA
Stock Option (right to buy)
2019-03-13+30,000→ 30,000 total
Award
ADMA BIOLOGICS, INC.$ADMA
Stock Option (right to buy)
2018-06-22+17,500→ 17,500 total
Purchase
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2018-06-08$4.78/sh+5,230→ 36,530 total
Purchase
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2017-11-09$2.15/sh+25,000→ 31,300 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Employee Stock Option (right to buy)
2017-07-13−2,800→ 0 total
Exercise/Conversion
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2017-07-13$2.68/sh+2,800→ 6,300 total
Award
ADMA BIOLOGICS, INC.$ADMA
Stock Option (right to buy)
2017-06-06+78,144→ 78,144 total
Award
ADMA BIOLOGICS, INC.$ADMA
Stock Option (right to buy)
2017-02-14+10,000→ 10,000 total
Exercise/Conversion
Altimmune, Inc.$ALT
Stock option (right to buy)
2016-11-22−20,000→ 0 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, $0.0001 par value per share
2016-11-22$1.71/sh+135,660→ 858,055 total
Exercise/Conversion
Altimmune, Inc.$ALT
Stock option (right to buy)
2016-11-22−20,000→ 0 total
Exercise/Conversion
Altimmune, Inc.$ALT
Stock Option (right to buy)
2016-11-22−240,000→ 0 total
Exercise/Conversion
Altimmune, Inc.$ALT
Stock Option (right to buy)
2016-11-22−30,573→ 0 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, $0.0001 par value per share
2016-11-22$2.20/sh+20,000→ 898,055 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, $0.0001 par value per share
2016-11-22$1.19/sh+37,500→ 482,395 total
Exercise/Conversion
Altimmune, Inc.$ALT
Stock Option (right to buy)
2016-11-22−37,500→ 0 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, $0.0001 par value per share
2016-11-22$1.94/sh+240,000→ 722,395 total
Exercise/Conversion
Altimmune, Inc.$ALT
Stock option (right to buy)
2016-11-22−135,660→ 0 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, $0.0001 par value per share
2016-11-22$2.46/sh+30,573→ 444,895 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, $0.0001 par value per share
2016-11-22$1.69/sh+20,000→ 878,055 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, $0.0001 par value per share
2016-09-28$1.48/sh+100,000→ 376,822 total
Exercise/Conversion
Altimmune, Inc.$ALT
Employee Stock Option (right to buy)
2016-09-28−37,500→ 37,500 total
Exercise/Conversion
Altimmune, Inc.$ALT
Employee Stock Option (right to buy)
2016-09-28−100,000→ 0 total
Exercise/Conversion
Altimmune, Inc.$ALT
Employee Stock Option (right to buy)
2016-09-28−100,000→ 0 total

RICHMAN ERIC I

Recent Transactions

Companies

Recent Filings

Address